Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Aminolevulinic acid/sodium ferrous citrate - SBI Pharmaceuticals

Next Previous
Search
Drug Profile

Aminolevulinic acid/sodium ferrous citrate - SBI Pharmaceuticals

Alternative Names: 5-ALA-SFC; Sodium ferrous citrate/aminolevulinic acid; SPP-003

Latest Information Update: 28 Nov 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator SBI Pharmaceuticals Co Ltd
  • Developer SBI Pharmaceuticals Co Ltd; University of Fukui; University of Tokyo
  • Class Amino acids; Antianaemics; Antineoplastics; Keto acids; Levulinic acids; Oxidants; Small molecules
  • Mechanism of Action Erythropoiesis stimulants; Photosensitisers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Chemotherapy-induced anaemia; Lung cancer
  • No development reported Autistic disorder; Malaria; Mitochondrial disorders; Type 2 diabetes mellitus

Most Recent Events

  • 28 Nov 2023 No recent reports of development identified for clinical-Phase-Unknown development in Autistic-disorder(In the elderly, In adults) in Japan (PO, Capsule)
  • 28 Nov 2023 No recent reports of development identified for research development in Mitochondrial disorders in Japan
  • 11 Jun 2022 Efficacy and adverse event data from pilot trial in Type-2 diabetes mellitus presented at the 104th Annual Meeting of the Endocrine Society (ENDO-2022)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top